Study Finds Pancreatic Tumor Differences by Race

Researchers at the University of Cincinnati report distinct immune and cellular features in pancreatic tumors from Black and non-African American patients.

Updated on Nov. 17, 2026 in Cancer

Study Finds Pancreatic Tumor Differences by Race

Live Poll

Do you trust that medical research fairly represents people of all racial backgrounds?

A University of Cincinnati study of 22 pancreatic tumors found that tumors from Black patients had fewer of the most common cancer cell type and more mixed-characteristic cells, with some of those traits linked to drug resistance. The findings were published in the journal Cancer Research.

Why it matters

Pancreatic cancer is approximately 20% more likely to develop in Black Americans than in non-African Americans, according to the researchers, and the tumor differences may help explain disparities in disease biology. Understanding these variations could inform future research into treatment approaches for patients across the United States.

The study analyzed 22 pancreatic tumors, seven from Black patients and 15 from non-African American patients, and reports pancreatic cancer is about 20% more likely in Black Americans. The sample is small, and the researchers have not yet determined whether these tumor differences affect treatment response or survival.

The players

University of Cincinnati

A public research university in Ohio whose researchers conducted the study on pancreatic tumor differences.

Cancer Research

A peer-reviewed scientific journal published by the American Association for Cancer Research that released the study findings.

National Cancer Institute

The federal agency within the National Institutes of Health that partly funded the research and leads the nation's cancer research efforts.

The details

Researchers compared cancer cells and immune responses in tumor samples from patients of different racial backgrounds. Tumors from Black patients contained more B cells and larger clusters of immune cells, while the major genetic changes known to drive the disease showed no significant differences between groups.

Timeline

  1. The study findings were published in Cancer Research on November 17, 2026.

Health Landscape

The findings add to ongoing National Cancer Institute-funded research into racial disparities in cancer, extending the question from incidence rates into tumor biology. The work is preliminary, but it points toward whether treatment strategies may need to account for differences in how tumors and immune cells behave across patient groups.

For people with pancreatic cancer, the findings suggest tumor biology may vary by race, which could eventually influence which treatments are considered most effective. Patients should continue to follow their oncologist's guidance, as the research has not yet changed any clinical recommendations.

The takeaway

Biological differences in tumors may contribute to cancer disparities, but larger studies are needed before these findings affect how pancreatic cancer is treated. Patients concerned about their risk should discuss screening and family history with their healthcare provider.

Further reading

Explore more on cancer research and how disease biology varies across patient populations.

Source note: This article includes information reported by Fox News.

Live Poll

Do you trust that medical research fairly represents people of all racial backgrounds?